Author: Duc Duy Nguyen; Kaifu Gao; Jiahui Chen; Rui Wang; Guo-Wei Wei
                    Title: Potentially highly potent drugs for 2019-nCoV  Document date: 2020_2_13
                    ID: g5wpa2ee_14
                    
                    Snippet: The top-ranking candidate of the existing drugs is Bortezomib (see Figure 3 (b)). Its predicted binding affinity to the nCoV-2019 protease is -12.29 kcal/mol. The high binding affinity is due to the strong hydrogen bond network formed between the drug and the nCoV-2019 protease. For example, the strongest hydrogen author/funder. All rights reserved. No reuse allowed without permission......
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: The top-ranking candidate of the existing drugs is Bortezomib (see Figure 3 (b)). Its predicted binding affinity to the nCoV-2019 protease is -12.29 kcal/mol. The high binding affinity is due to the strong hydrogen bond network formed between the drug and the nCoV-2019 protease. For example, the strongest hydrogen author/funder. All rights reserved. No reuse allowed without permission.
 
  Search related documents: 
                                Co phrase  search for related documents- bind affinity and hydrogen bond: 1, 2
  - bind affinity and protease bind affinity: 1, 2, 3
  - bind affinity and protease drug: 1, 2, 3
  - binding affinity and high binding affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80
  - binding affinity and hydrogen bond: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
  - binding affinity and hydrogen bond network: 1, 2, 3, 4
  - binding affinity and protease bind affinity: 1, 2
  - binding affinity and protease drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
  - binding affinity and protease drug form: 1
  - high binding affinity and hydrogen bond: 1, 2, 3, 4, 5
  - high binding affinity and hydrogen bond network: 1
  - high binding affinity and protease bind affinity: 1
  - high binding affinity and protease drug: 1, 2, 3
  - hydrogen bond and protease drug: 1, 2, 3, 4, 5, 6, 7
  - hydrogen bond and protease drug form: 1
  - permission allow and protease drug: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date